{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:08:53Z","timestamp":1791493733086,"version":"4.3.4"},"reference-count":102,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2014,2,4]],"date-time":"2014-02-04T00:00:00Z","timestamp":1391472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Inher Metab Disea"],"published-print":{"date-parts":[[2014,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Current available evidence on long\u2010term effectiveness of enzyme replacement therapy (ERT) for Fabry disease is limited. More insight is needed whether ERT effectiveness differs in patients with and without baseline end\u2010organ damage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Through a systematic review, untreated and ERT treated males and females with Fabry disease were compared for main clinical outcomes: renal function, left ventricular mass (LVmass), cerebral white matter lesions (WMLs) and end\u2010organ complications. Through a meta\u2010analysis ERT effectiveness was estimated in different disease stages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data extraction<\/jats:title>\n                    <jats:p>Two reviewers assessed quality of the included studies according to guidelines for prognosis research. Data were synthesized using a random effects meta\u2010analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thirty\u2010one studies were systematically reviewed while six studies were included in the meta\u2010analysis. In patients with a GFR\u2009&gt;\u200960 ml\/min\/1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      , decline of renal function was similar for treated and untreated patients. Only ERT treated males with a GFR\u2009&lt;\u200960 ml\/min\/1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      had a slower rate of decline in renal function, possibly attributable to anti\u2010proteinuric therapy. Regardless of left ventricular hypertrophy (LVH) at baseline, LVmass remained stable or increased in males despite ERT, however at a slower rate compared to untreated male patients. In ERT treated females with LVH LVmass decreased, and remained stable in females without LVH. WMLs can not be prevented by ERT. Stroke, cardiac and end\u2010stage renal complications develop, though the incidence of new complications seems to be reduced during ERT.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ERT is effective in reducing LVH, but has a limited effect on renal function. Improved treatment options are needed for Fabry disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10545-014-9677-8","type":"journal-article","created":{"date-parts":[[2014,2,3]],"date-time":"2014-02-03T10:08:41Z","timestamp":1391422121000},"page":"341-352","source":"Crossref","is-referenced-by-count":117,"title":["Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta\u2010analysis"],"prefix":"10.1002","volume":"37","author":[{"given":"Saskia M.","family":"Rombach","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism Academic Medical Center PO Box 22660 Amsterdam 1100 DD The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouwien E.","family":"Smid","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism Academic Medical Center PO Box 22660 Amsterdam 1100 DD The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor E.","family":"Linthorst","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism Academic Medical Center PO Box 22660 Amsterdam 1100 DD The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel G. W.","family":"Dijkgraaf","sequence":"additional","affiliation":[{"name":"Clinical Research Unit Academic Medical Center PO Box 22660 Amsterdam 1100 DD The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla E. M.","family":"Hollak","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism Academic Medical Center PO Box 22660 Amsterdam 1100 DD The Netherlands"},{"name":"Department of Internal Medicine\/Endocrinology and Metabolism Academic Medical Center Meibergdreef 9 Amsterdam 1105 AZ The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,2,4]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1415-47572012000600009"},{"key":"e_1_2_11_3_1","first-page":"69","article-title":"Enzyme replacement therapy for Fabry disease: some answers but more questions","volume":"7","author":"Alfadhel M","year":"2011","journal-title":"Ther Clin Risk Manag"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:BOLI.0000005658.14563.77"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-2-200701160-00148"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2004.01424.x"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.11.087"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-006-0361-5"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2012.01947.x"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196705252762101"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200203000-00003"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000208"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.143693"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/1741826710391118"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.6.1746"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2005.036327"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"e_1_2_11_18_1","first-page":"3733","article-title":"alpha\u2010Galactosidase A deficiency: Fabry disease","volume":"8","author":"Desnick RJ","year":"2001","journal-title":"The metabolic and molecular bases of inherited disease"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006663.pub3"},{"key":"e_1_2_11_20_1","doi-asserted-by":"crossref","unstructured":"El DibRP PastoresGM(2010)Enzyme replacement therapy for Anderson\u2010Fabry disease.Cochrane Database Syst Rev CD006663.","DOI":"10.1002\/14651858.CD006663.pub2"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2004.054015"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-007-0521-2"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107053450102"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-000879"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-005-0575-y"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1159\/000168482"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03130411"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006080816"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0303-8467(92)90079-I"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.40.4.e38"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000178976.62537.6b"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-6-200603210-00010"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-16"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2011.03.022"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.104026"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2008.162800"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:BOLI.0000028794.04349.91"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-282X2006000500002"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-006-0221-3"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2008.03.007"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.09.008"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2008.00700.x"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.167.3922.1268"},{"key":"e_1_2_11_45_1","unstructured":"KobayashiM OhashiT SakumaM IdaH EtoY(2008)Clinical manifestations and natural history of Japanese heterozygous females with Fabry disease.J Inherit Metab Disdoi:10.1007\/s10545\u2010007\u20100740\u20106"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-008-0848-3"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/ejechocard\/jen129"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-2-200307150-00013"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e3181f13b75"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e3181981d82"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.38.11.769"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.38.11.750"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61493-8"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2004.01309.x"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-011-0710-9"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410400105"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-2-4"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2012.05.011"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199508033330504"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2010.204586"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp554"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.11.018"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.03.016"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/8904_2012_177"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2010.02101.x"},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2011.01671.x"},{"key":"e_1_2_11_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2007.00029.x"},{"key":"e_1_2_11_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2011.03.020"},{"key":"e_1_2_11_69_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-2895"},{"key":"e_1_2_11_70_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047805"},{"key":"e_1_2_11_71_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-47"},{"key":"e_1_2_11_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2009.01.003"},{"key":"e_1_2_11_73_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006111263"},{"key":"e_1_2_11_74_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.21.2743"},{"issue":"832","key":"e_1_2_11_75_1","first-page":"837","article-title":"Four\u2010year prospective clinical trial of agalsidase alfa in children with Fabry disease","volume":"156","author":"Schiffmann R","year":"2010","journal-title":"J Pediatr"},{"key":"e_1_2_11_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfi152"},{"key":"e_1_2_11_77_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp031"},{"key":"e_1_2_11_78_1","first-page":"77","article-title":"Enzyme replacement therapy and renal function in 201 patients with Fabry disease","volume":"66","author":"Schwarting A","year":"2006","journal-title":"Clin Nephrol"},{"key":"e_1_2_11_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.05.033"},{"key":"e_1_2_11_80_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2004.035584"},{"key":"e_1_2_11_81_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.526293"},{"key":"e_1_2_11_82_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-69"},{"key":"e_1_2_11_83_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2004.00284.x"},{"key":"e_1_2_11_84_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006121400"},{"key":"e_1_2_11_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2007.12.001"},{"key":"e_1_2_11_86_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012030316"},{"key":"e_1_2_11_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2012.39"},{"key":"e_1_2_11_88_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000598"},{"key":"e_1_2_11_89_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-006-0484-8"},{"key":"e_1_2_11_90_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04340510"},{"key":"e_1_2_11_91_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr420"},{"key":"e_1_2_11_92_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr420"},{"key":"e_1_2_11_93_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000091253.71282.04"},{"key":"e_1_2_11_94_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.794529"},{"key":"e_1_2_11_95_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12077"},{"key":"e_1_2_11_96_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008080870"},{"key":"e_1_2_11_97_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002374"},{"key":"e_1_2_11_98_1","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e3181a23bec"},{"key":"e_1_2_11_99_1","doi-asserted-by":"publisher","DOI":"10.1086\/422366"},{"key":"e_1_2_11_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2007.09.013"},{"issue":"563","key":"e_1_2_11_101_1","first-page":"570","article-title":"Safety and efficacy of enzyme replacement therapy with agalsidase beta: an international, open\u2010label study in pediatric patients with Fabry disease","volume":"152","author":"Wraith JE","year":"2008","journal-title":"J Pediatr"},{"key":"e_1_2_11_102_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1281744"},{"key":"e_1_2_11_103_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta16390"}],"container-title":["Journal of Inherited Metabolic Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10545-014-9677-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T01:22:48Z","timestamp":1694740968000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/s10545-014-9677-8"}},"subtitle":["Effectiveness of ERT in different disease stages"],"short-title":[],"issued":{"date-parts":[[2014,2,4]]},"references-count":102,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["10.1007\/s10545-014-9677-8"],"URL":"https:\/\/doi.org\/10.1007\/s10545-014-9677-8","archive":["Portico"],"relation":{},"ISSN":["0141-8955","1573-2665"],"issn-type":[{"value":"0141-8955","type":"print"},{"value":"1573-2665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,4]]}}}